deCode Genetics

Acquired

24front

Reykjavik, Iceland · Founded 1996 · $173.0M raised

Headquarters
Reykjavik
Employees
201–500
Founded
1996
Business Model
B2B
Website
decode.com
Total Funding
$173.0M
Last Round
$173.0M Venture RoundJul 2000
Rounds
1
Acquisition Date
Dec 2012

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

deCODE genetics, an Amgen subsidiary headquartered in Reykjavik, Iceland, is a global leader in analyzing the human genome to identify genetic risk factors for common diseases. Using Iceland's unique population genetics resources, deCODE has discovered risk factors for dozens of conditions including cardiovascular disease, cancer, and neurological disorders, advancing drug discovery and development.

Summary

deCode Genetics is a Biotech company based in Reykjavik, Iceland, founded in 1996. It has raised $173.0M in total across 1 round, most recently a $173.0M Venture Round in Jul 2000. Investors include Amgen, ARCH Venture Partners and Polaris Partners.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionDec 2012

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

deCode Genetics on Indexed.vc
<a href="https://indexed.vc/companies/decode-genetics"><img src="https://indexed.vc/api/badge/company/decode-genetics" alt="deCode Genetics on Indexed.vc" width="260" height="76" /></a>